SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701541-23-000041
Filing Date
2023-08-11
Accepted
2023-08-11 07:26:36
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdtx-20230630.htm   iXBRL 10-Q 870276
2 EX-31.1 exhibit311_q22023.htm EX-31.1 12490
3 EX-31.2 exhibit312_q22023.htm EX-31.2 12261
4 EX-32.1 exhibit321_q22023.htm EX-32.1 9313
  Complete submission text file 0001701541-23-000041.txt   4662788

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdtx-20230630.xsd EX-101.SCH 31010
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdtx-20230630_cal.xml EX-101.CAL 51919
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdtx-20230630_def.xml EX-101.DEF 124110
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdtx-20230630_lab.xml EX-101.LAB 451575
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdtx-20230630_pre.xml EX-101.PRE 283379
55 EXTRACTED XBRL INSTANCE DOCUMENT bdtx-20230630_htm.xml XML 615980
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39200 | Film No.: 231161516
SIC: 2836 Biological Products, (No Diagnostic Substances)